N-acetylcysteineamide protects against manganese-induced toxicity in SHSY5Y cell line

[1]  S. Tobwala,et al.  Comparative evaluation of N-acetylcysteine and N-acetylcysteineamide in acetaminophen-induced hepatotoxicity in human hepatoma HepaRG cells , 2015, Experimental biology and medicine.

[2]  M. Aschner,et al.  Manganese neurotoxicity and the role of reactive oxygen species. , 2013, Free radical biology & medicine.

[3]  G. Di Bari,et al.  Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  T. Stoeger,et al.  N-acetylcysteine amide, a thiol antioxidant, prevents bleomycin-induced toxicity in human alveolar basal epithelial cells (A549) , 2013, Free radical research.

[5]  M. Aschner,et al.  In Vivo Manganese Exposure Modulates Erk, Akt and Darpp-32 in the Striatum of Developing Rats, and Impairs Their Motor Function , 2012, PloS one.

[6]  S. Tobwala,et al.  N-Acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice , 2012, Human & experimental toxicology.

[7]  M. Aschner,et al.  Protective effects of ebselen (Ebs) and para-aminosalicylic acid (PAS) against manganese (Mn)-induced neurotoxicity. , 2012, Toxicology and applied pharmacology.

[8]  M. Aschner,et al.  Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury. , 2011, Toxicology and applied pharmacology.

[9]  Hyonok Yoon,et al.  The effects of 3, 4 or 5 amino salicylic acids on manganese-induced neuronal death: ER stress and mitochondrial complexes. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  M. Aschner,et al.  Prolactin is a peripheral marker of manganese neurotoxicity , 2011, Brain Research.

[11]  N. Ercal,et al.  Comparative evaluation of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice. , 2011, Toxicology letters.

[12]  N. Zeghal,et al.  Silymarin, a natural antioxidant, protects cerebral cortex against manganese-induced neurotoxicity in adult rats , 2010, BioMetals.

[13]  M. Aschner,et al.  Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. , 2009, Toxicology and applied pharmacology.

[14]  D. Hagen,et al.  N-acetylcysteineamide (NACA) prevents inflammation and oxidative stress in animals exposed to diesel engine exhaust. , 2009, Toxicology letters.

[15]  M. Aschner,et al.  Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. , 2009, Chemical reviews.

[16]  W. Banks,et al.  N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells , 2009, Brain Research.

[17]  M. Aschner,et al.  Antioxidants prevent the cytotoxicity of manganese in RBE4 cells , 2008, Brain Research.

[18]  Yu Deng,et al.  In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. , 2008, Environmental toxicology and pharmacology.

[19]  C. Tamm,et al.  Mitochondrial-mediated apoptosis in neural stem cells exposed to manganese. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  B. Ateş,et al.  Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC) , 2008, Free radical research.

[21]  A. Iwashita,et al.  Novel neuroprotective compound SCH-20148 rescues thymocytes and SH-SY5Y cells from thapsigargin-induced mitochondrial membrane potential reduction and cell death. , 2007, European journal of pharmacology.

[22]  M. Aschner,et al.  Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Michael Aschner,et al.  Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. , 2006, Neurotoxicology.

[24]  M. Aschner,et al.  Effects of inhaled manganese on biomarkers of oxidative stress in the rat brain. , 2006, Neurotoxicology.

[25]  M. Norenberg,et al.  Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment , 2006, Neuroscience Letters.

[26]  E. Melamed,et al.  A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease , 2005, The European journal of neuroscience.

[27]  M. Aschner,et al.  Manganese exposure and induced oxidative stress in the rat brain. , 2004, The Science of the total environment.

[28]  M. Norenberg,et al.  Manganese Induces the Mitochondrial Permeability Transition in Cultured Astrocytes* , 2004, Journal of Biological Chemistry.

[29]  M. Aschner,et al.  Airborne manganese exposure differentially affects end points of oxidative stress in an age-and sex-dependent manner , 2004, Biological Trace Element Research.

[30]  Michael Aschner,et al.  Manganese-induced cytotoxicity in dopamine-producing cells. , 2004, Neurotoxicology.

[31]  Guoyao Wu,et al.  Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.

[32]  C. Olanow,et al.  Manganese‐Induced Parkinsonism and Parkinson's Disease , 2004, Annals of the New York Academy of Sciences.

[33]  Surong Zhang,et al.  In vitro effect of manganese chloride exposure on reactive oxygen species generation and respiratory chain complexes activities of mitochondria isolated from rat brain. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[34]  J. Roth,et al.  Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. , 2003, Biochemical pharmacology.

[35]  A. Hazell,et al.  Manganese Neurotoxicity: An Update of Pathophysiologic Mechanisms , 2002, Metabolic Brain Disease.

[36]  S. Liao,et al.  Oxidative Stress Involves in Astrocytic Alterations Induced by Manganese , 2002, Experimental Neurology.

[37]  P. Hantson,et al.  Carcinogenicity, mutagenicity and teratogenicity of manganese compounds. , 2002, Critical reviews in oncology/hematology.

[38]  I. Date,et al.  The role of dopamine in manganese-induced oxidative injury in rat pheochromocytoma cells , 2002, Human & experimental toxicology.

[39]  S. Bondy,et al.  Modulation of oxidative events by multivalent manganese complexes in brain tissue. , 2001, Free radical biology & medicine.

[40]  W. Zheng,et al.  Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes. , 2001, Toxicology and applied pharmacology.

[41]  E. Malecki.  Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons , 2001, Brain Research Bulletin.

[42]  K. Cousins,et al.  Paradoxical effects of copper and manganese on brain mitochondrial function. , 2001, Life sciences.

[43]  M. Banaclocha.  N-Acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson's disease , 2000, Brain Research.

[44]  R. Agarwal,et al.  Potential Role of Cerebral Glutathione in the Maintenance of Blood-Brain Barrier Integrity in Rat , 1999, Neurochemical Research.

[45]  J. Joseph,et al.  Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. , 1999, Free radical biology & medicine.

[46]  A. Zhong,et al.  UCP4, a novel brain‐specific mitochondrial protein that reduces membrane potential in mammalian cells , 1999, FEBS letters.

[47]  J M Dubinsky,et al.  Calcium‐induced activation of the mitochondrial permeability transition in hippocampal neurons , 1998, Journal of neuroscience research.

[48]  A. Halestrap,et al.  Oxidative Stress, Thiol Reagents, and Membrane Potential Modulate the Mitochondrial Permeability Transition by Affecting Nucleotide Binding to the Adenine Nucleotide Translocase* , 1997, The Journal of Biological Chemistry.

[49]  P. Fumagalli,et al.  Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese. , 1995, European journal of pharmacology.

[50]  W. Slikker,et al.  Manganese-induced reactive oxygen species: comparison between Mn+2 and Mn+3. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[51]  D. Spitz,et al.  Analysis of glutathione, glutathione disulfide, cysteine, homocysteine, and other biological thiols by high-performance liquid chromatography following derivatization by n-(1-pyrenyl)maleimide. , 1995, Analytical biochemistry.

[52]  G. Esposito,et al.  Cellular defence mechanisms in the striatum of young and aged rats subchronically exposed to manganese , 1995, Neuropharmacology.

[53]  Etelvino J. H. Bechara,et al.  Permeabilization of the inner mitochondrial membrane by Ca2+ ions is stimulated by t-butyl hydroperoxide and mediated by reactive oxygen species generated by mitochondria. , 1995, Free radical biology & medicine.

[54]  K. Gunter,et al.  Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. , 1990, The Biochemical journal.

[55]  D B Calne,et al.  Chronic manganese intoxication. , 1989, Archives of neurology.

[56]  M. Maines,et al.  Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. , 1988, The Journal of pharmacology and experimental therapeutics.

[57]  W. Wilmanns,et al.  Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. , 1988, Biochemical pharmacology.

[58]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[59]  H. Karacal,et al.  In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide. , 2011, Free radical biology & medicine.

[60]  D. Atlas,et al.  N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. , 2005, Free radical biology & medicine.

[61]  I. Cotgreave,et al.  N-acetylcysteine: pharmacological considerations and experimental and clinical applications. , 1997, Advances in pharmacology.

[62]  J. Coyle,et al.  Oxidative stress in neurodegenerative diseases. , 1996, Annual review of pharmacology and toxicology.

[63]  A. Meister.  [1] Glutathione metabolism , 1995 .